|
|
||||||||



Departments of
*
Pathology and
Pediatrics and
Division of Infectious Disease, Case Western Reserve University, Cleveland, OH 44106
Certain microbial substances, e.g., LPS, can activate neutrophils or prime them to enhance their response to other activating agents, e.g., fMLP. We investigated the role of the Mycobacterium tuberculosis (MTB) 19-kDa lipoprotein in activation of human neutrophils. MTB 19-kDa lipoprotein initiated phenotypic changes characteristic of neutrophil activation, including down-regulation of CD62 ligand (L-selectin) and up-regulation of CD35 (CR1) and CD11b/CD18 (CR3, Mac-1). In addition, exposure of neutrophils to MTB 19-kDa lipoprotein enhanced the subsequent oxidative burst in response to fMLP as assessed by oxidation of dihydrorhodamine 123 (determined by flow cytometry). LPS also produced these effects with similar kinetics, but an oligodeoxynucleotide containing a CpG motif failed to induce any priming or activation response. Although the effects of LPS required the presence of serum, neutrophil activation by MTB 19-kDa lipoprotein occurred independently of serum factors, suggesting the involvement of different receptors and signaling mechanisms for LPS and MTB 19-kDa lipoprotein. Thus, MTB 19-kDa lipoprotein serves as a pathogen-associated molecular pattern that promotes neutrophil priming and activation.
This article has been cited by other articles:
![]() |
M. Bastian, T. Braun, H. Bruns, M. Rollinghoff, and S. Stenger Mycobacterial Lipopeptides Elicit CD4+ CTLs in Mycobacterium tuberculosis-Infected Humans J. Immunol., March 1, 2008; 180(5): 3436 - 3446. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Babu, M. L. Priya, A. T. Selvan, M. Madera, J. Gough, L. Aravind, and K. Sankaran A Database of Bacterial Lipoproteins (DOLOP) with Functional Assignments to Predicted Lipoproteins. J. Bacteriol., April 1, 2006; 188(8): 2761 - 2773. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Parker, M. K. B. Whyte, S. K. Dower, and I. Sabroe The expression and roles of Toll-like receptors in the biology of the human neutrophil J. Leukoc. Biol., June 1, 2005; 77(6): 886 - 892. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. B. Eruslanov, I. V. Lyadova, T. K. Kondratieva, K. B. Majorov, I. V. Scheglov, M. O. Orlova, and A. S. Apt Neutrophil Responses to Mycobacterium tuberculosis Infection in Genetically Susceptible and Resistant Mice Infect. Immun., March 1, 2005; 73(3): 1744 - 1753. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Radsak, H. R. Salih, H.-G. Rammensee, and H. Schild Triggering Receptor Expressed on Myeloid Cells-1 in Neutrophil Inflammatory Responses: Differential Regulation of Activation and Survival J. Immunol., April 15, 2004; 172(8): 4956 - 4963. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Tsolaki, A. E. Hirsh, K. DeRiemer, J. A. Enciso, M. Z. Wong, M. Hannan, Y.-O. L. G. de la Salmoniere, K. Aman, M. Kato-Maeda, and P. M. Small From the Cover: Functional and evolutionary genomics of Mycobacterium tuberculosis: Insights from genomic deletions in 100 strains PNAS, April 6, 2004; 101(14): 4865 - 4870. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lotz, E. Aga, I. Wilde, G. van Zandbergen, T. Hartung, W. Solbach, and T. Laskay Highly purified lipoteichoic acid activates neutrophil granulocytes and delays their spontaneous apoptosis via CD14 and TLR2 J. Leukoc. Biol., March 1, 2004; 75(3): 467 - 477. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Feng, C. A. Scanga, C. M. Collazo-Custodio, A. W. Cheever, S. Hieny, P. Caspar, and A. Sher Mice Lacking Myeloid Differentiation Factor 88 Display Profound Defects in Host Resistance and Immune Responses to Mycobacterium avium Infection Not Exhibited by Toll-Like Receptor 2 (TLR2)- and TLR4-Deficient Animals J. Immunol., November 1, 2003; 171(9): 4758 - 4764. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Hayashi, T. K. Means, and A. D. Luster Toll-like receptors stimulate human neutrophil function Blood, October 1, 2003; 102(7): 2660 - 2669. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Suttmann, N. Lehan, A. Bohle, and S. Brandau Stimulation of Neutrophil Granulocytes with Mycobacterium bovis Bacillus Calmette-Guerin Induces Changes in Phenotype and Gene Expression and Inhibits Spontaneous Apoptosis Infect. Immun., August 1, 2003; 71(8): 4647 - 4656. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. R. Tobian, N. S. Potter, L. Ramachandra, R. K. Pai, M. Convery, W. H. Boom, and C. V. Harding Alternate Class I MHC Antigen Processing Is Inhibited by Toll-Like Receptor Signaling Pathogen-Associated Molecular Patterns: Mycobacterium tuberculosis 19-kDa Lipoprotein, CpG DNA, and Lipopolysaccharide J. Immunol., August 1, 2003; 171(3): 1413 - 1422. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Smith Mycobacterium tuberculosis Pathogenesis and Molecular Determinants of Virulence Clin. Microbiol. Rev., July 1, 2003; 16(3): 463 - 496. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Fulton, S. M. Reba, T. D. Martin, and W. H. Boom Neutrophil-Mediated Mycobacteriocidal Immunity in the Lung during Mycobacterium bovis BCG Infection in C57BL/6 Mice Infect. Immun., September 1, 2002; 70(9): 5322 - 5327. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |